Shares of Applied DNA Sciences Inc. (APDN) are surging over 81% in pre-market today, after the company announced that the U.S. FDA has provided Emergency Use Authorization or EUA for the clinical use of the company's patent-pending Linea COVID-19 RT-PCR test for COVID-19.
from RTT - Before the Bell https://ift.tt/3cB8MyA
via IFTTT
No comments:
Post a Comment